Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Controlled Substances Scheduling topic
No spam. Unsubscribe anytime.
Committee introduces drug‑scheduling updates adding synthetic substances and a new postpartum medication to state schedules
Summary
The Idaho Board of Pharmacy’s update to the Uniform Controlled Substances Act, filed as RS 31822, would add dozens of synthetic drugs to state schedules and place the FDA‑approved postpartum drug zuranolone on Schedule IV, the board’s executive officer told the House Health and Welfare Committee.
Nikki Chopsky, Health Professions Bureau Chief in the Division of Occupational and Professional Licenses and executive officer for the boards of medicine, nursing and pharmacy, presented RS 31822 on behalf of the Idaho Board of Pharmacy.
Chopsky said the bill updates Idaho’s Uniform Controlled Substances Act to add 24 illicit substances (including benzodiazepine derivatives, synthetic fentanyls, synthetic cannabinoids and synthetic cathinones) to Schedule I; to add 23 man‑made testosterone derivatives to Schedule III; and to add zuranolone (marketed as Zirzuve), a new FDA‑approved medication for postpartum depression, to Schedule IV. "On pages 1 through 10, the bill adds 24 illicit substances...","On pages 12 [and] 13, the bill proposes 23 man made testosterone derivatives to schedule 3," and "on page 16, the bill adds zuranolone, also known as Zirzuve, a new FDA approved medication for the treatment of postpartum depression to schedule 4," she said.
Chopsky told the committee the board discussed the proposed language at two public meetings beginning in September 2024 and that no public feedback had been received to date. She also said key stakeholders were engaged and that the board did not currently anticipate fiscal impact to the general fund.
Representative Healy moved to introduce RS 31822. The committee voted by voice to introduce the measure; the chair said the motion carries and no opposition was recorded. Chopsky told the committee she would provide a line‑by‑line presentation if the bill is printed for a formal hearing.
The proposed scheduling changes will be subject to a committee bill hearing and statutory review if printed.
